Top Markets
#1 Bedrock Bedrock +42.69%
#2 Talus Network Talus Network +24.65%
#3 API3 API3 +20.65%
#4 CyberDEX CyberDEX +19.21%
#5 iExec RLC iExec RLC +18.52%
#6 Radicle Radicle +16.37%
#7 The Bitcoin Bull The Bitcoin Bull +16.37%
#8 VeThor VeThor +13.05%
#9 Verus Coin Verus Coin +11.08%
#10 Rollbit Coin Rollbit Coin +10.44%
Coin of the day
Bedrock Bedrock
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Rang in aandelen #28220
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Aandeelprijs
$0.4
Laatst gesynchroniseerd: 2026-10-02
Marktkapitalisatie
$27.18M
Verandering (1 dag)
-14.88%
Verandering (1 jaar)
8.11%
Land
US
Handel Cell Source, Inc. (CLCS)

Categorie

Healthcare
P/S-ratio voor Cell Source, Inc. (CLCS)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Cell Source, Inc. is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Cell Source, Inc. van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.51 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
34.29 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.77 -
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
11.49 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH